- Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group. Fosså, S.D., Slee, P.H., Brausi, M., Horenblas, S., Hall, R.R., Hetherington, J.W., Aaronson, N., de Prijck L, n.u.l.l., Collette, L. J. Clin. Oncol. (2001)